Abstract
Introduction/Background*Most patients diagnosed of advanced epithelial ovarian cancer (EOC) will relapse within the first years after the treatment. It is fundamental to find a marker for recurrence monitoring. Our objective...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
